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Abstract
Oral and pharyngeal cancers are the sixth most common cancers internationally. In the United States, there are
about 30,000 new cases of oral and pharyngeal cancers diagnosed each year. Furthermore, survival rates for oral
and pharyngeal cancers have not significantly improved over the last three decades. This review examines the
scientific literature surrounding the epidemiology of oral and pharyngeal cancers, including but not limited to risk
factors, disparities, preventative factors, and the epidemiology in countries outside the United States. The literature
review revealed that much of the research in this field has been focused on alcohol, tobacco, and their combined
effects on oral and pharyngeal cancers. The literature on oral and pharyngeal cancer disparities among racial
groups also appears to be growing. However, less literature is available on the influence of dietary factors on these
cancers. Finally, effective interventions for the reduction of oral and pharyngeal cancers are discussed.
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Introduction
Oral and pharyngeal cancers (OPC) are considered an
important part of the global burden of cancer, mainly
due to the widespread use of tobacco and alcohol. In
the United States, cancers of the oral cavity account for
nearly 2.3% of cancers and also have a relatively low
five-year survival rate [1]. There are also nearly 30,000
new cases of OPC diagnosed each year in the United
States with about 8,000 people dying of these malignan-
cies and evidence of little improvement in five-year sur-
vival rates from 1973-1998 [2-4]. In addition, OPC are
among the most common (sixth most) cancers interna-
tionally [5,6]. Moreover, tobacco and alcohol use attri-
bute significantly to the risk of developing these types of
malignancies. The population-attributable risk of smok-
ing and alcohol use for developing OPC has been esti-
mated at 80% for males, 61% for females, and 74% in
general [7].
Though much of the literature on OPC risk factors is
dominated by tobacco studies, there have been several
studies that have established the protective effects of a
healthful diet. Certain protective factors against develop-
ing OPC include the consumption of coffee, vegetables,
fruit, and dietary folate intake [8,9]. Other protective
factors may include socioeconomic-based variables. The
literature points to a differential distribution of OPC
among minorities and other sub-populations. There
seems to be a disproportional burden of OPC among
certain sub-populations within and outside of the United
States. For example, studies in the United States have
shown disparities in OPC between Appalachian states
and non-Appalachian states [1], low socioeconomic and
higher socioeconomic status populations [10], black and
white Americans [11], and males and females [12]. Dis-
parities also exist in places outside of the United States,
such as Taiwan [13]. Globally, significant differences in
the incidence of OPC have been observed by country,
with men in northern France and southern India having
the highest OPC incidence rates when compared to 47
other countries [14].
This review examines the scientific literature sur-
rounding OPC, including but not limited to OPC risk
factors, OPC disparities, OPC preventative factors, and
OPC in countries outside the United States.
Literature review methodology
The methods for the inclusion of scientific articles in
this review are liberal in nature. This review does not
aim to be wholly comprehensive of all the literature on
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the literature, and discusses the most important finding
in each study. No exclusion criteria were applied when
deciding which scientific articles would be included in
this review. The search engines PubMed [15], and Goo-
gle Scholar [16] were used to locate the most relevant
articles pertaining to oral and pharyngeal cancers,
regardless of year published. Thus, this review includes
studies from 1988 to 2009. Furthermore, a wide time
frame was used to determine whether later studies dif-
fered in their results than earlier ones, and to assess
how OPC related research has changed over time. Key-
words in these searches included ‘oral’ and ‘pharyngeal’
and ‘cancers’. Other keyword searches included ‘oral
and pharyngeal cancers’, ‘OPC malignancies’, ‘OPC risk
factors’,a n d‘OPC disparities’. Table 1 presents a por-
tion of the literature review on risk and protective fac-
tors for OPC.
Also, unlike conditions such as the metabolic syn-
drome (MetS) where the definition is not wholly
agreed upon or standardized [17], there was no evi-
d e n c ei nt h el i t e r a t u r et h a tt h i sw a st h ec a s ef o rO P C .
The International Classification of Diseases, Tenth
Revision (ICD-10) defines OPC as any malignant neo-
plasm of lip, oral cavity (tongue, major salivary glands,
gum, floor of mouth, other and unspecified parts of
mouth), and pharynx (oropharynx, nasopharynx, and
hypopharynx) [18].
Risk factors
Tobacco and alcohol
Tobacco use is understood to be the most important
risk factor for the development of OPC [7]. Much of the
literature on OPC risk factors is focused specifically on
tobacco use. For example, Rodriguez et al (2004) ana-
l y z e dd a t af r o mt w oc a s e - c o n t r o ls t u d i e si n c l u d i n g1 3 7
cases of OPC and showed that the multivariate odds
ratios (OR) for having OPC for heavy smokers was 20.7
in young adults from Italy and Switzerland. Rodriguez et
al found that the OR for heavy drinkers for OPC was
4.9 [8]. However, when the categories of heavy drinking
and smoking were combined, an OR of over 48 was
observed. The authors also found that tobacco
accounted for 77% of OPC cases in the examined popu-
lation, alcohol for 52%, low vegetable consumption for
52%, and the combination of the three for nearly 85% of
all OPC cases [8].
A separate case-control study performed on Italian
and Swiss men also found large risk increases for oral
cancer (OR = 228) and pharyngeal cancer (OR = 100)
for the highest level of drinking (≥ 77 drinks/week) and
smoking (≥ 25 cigarettes/day) combined [19]. The
authors of this study found there to be synergistic
effects of smoking and alcohol consumption on OPC.
The authors found interesting independent factors in
that if alcohol consumption increased while smoking
levels were stable, the increase in oral cancer would be
greater than the increase in pharyngeal cancer. This was
shown to be the case in this study because the authors
explain that the ratios of ORs between oral cancer and
pharyngeal cancer was about 2-times greater for oral
cancer than for pharyngeal cancer for each combined
level of smoking and drinking.
In addition, alcohol consumption has been shown to
be associated with increased odds of OPC among never
smokers. Fioretti et al (1999) examined 42 cases of OPC
among never smokers and found that the major risk fac-
tor for OPC in never smokers was alcohol consumption,
with an OR three-fold higher in drinkers than non-drin-
kers [20].
Another case-control study that confirmed a multipli-
cative synergism between smoking and alcohol con-
sumption on OPC examined 1,114 cases and 1,268
controls. Similar results were found as the above studies
in that among those that smoked two or more packs of
cigarettes and four or more drinks per day, there was an
observed 35-fold increase in the risk of OPC. The
authors estimate that smoking and drinking combined
account for about 75% of all OPC in the United States
[21]. A similar study in a Spanish male population
found that tobacco smoking was associated with OPC
with an OR of 27.7 [22]. These studies combined con-
firm the magnitude that smoking and alcohol consump-
tion have on OPC.
Moreover, a study examining the separate effects of
alcohol in non-smokers and smoking in non-drinkers
also found results similar to the above studies cited.
This study was performed essentially to test the relative
independence that smoking and alcohol consumption
has on the development of OPC. The ORs were 1.5 for
14-55 versus 0-13 drinks per week, and 2.2 for 56 drinks
or more in non-smokers. The ORs for non-drinkers who
smoked were 3.8 for smokers of < 15 cigarettes per day
and 12.9 for ≥ 15 cigarettes per day [23]. This is an
important study in the literature because it establishes
the independence that smoking and drinking have on
the development of OPC.
Interestingly, two studies found that among male cur-
rent smokers, those that used filter cigarettes had a
reduced risk of oral cancer than those who used non-fil-
ter cigarettes [21,24]. However, little research has been
performed on this topic, thus the results should be
interpreted with caution.
Dietary risk factors
Less research has been focused on risk factors besides
smoking and drinking and their relationship with OPC.
However, there is some evidence that meat, vegetable,
and vitamin intake may be related to OPC. A case-
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Authors
(Ref.)
Year
Published
Study Location Study Type Cases Control Study Results
Rodriguez T
et al. [8]
2004 Italy, Switzerland Case-Control 137 298 Heavy Smokers OR = 20.7; Heavy drinkers OR = 4.9; High tobacco and alcohol
OR = 48; High coffee consumption OR = 0.25; High vegetable consumption OR
= 0.39; High fruit consumption OR = 0.73; High beta carotene consumption OR
= 0.48
Pelucchi C,
et al. [9]
2003 Italy, Switzerland Case-Control 749 1772 Highest tertile of dietary folate intake OR = 0.53; Combined OR for low folate
and high alcohol OR = 22.3
Greenberg
RS, et al. [10]
1991 United States Case-Control 762 837 Low percentage of years worked OR = 2.3
Day GL, et al.
[11]
1993 United States Case-Control 1065 1182 Heavy drinking among blacks OR = 17; Heavy drinking among whites OR = 9;
Cook MB, et
al. [12]
2009 United States Retrospective - - Male-to-female incidence rate ratio hypopharynx = 4.13; Male-to-female
incidence rate ratio oropharynx = 3.06
Ho PS, et al.
[13]
2007 Taiwan Retrospective - - Highest age-standardized mortality rate for females of aboriginal groups = 3.76;
Highest age standardized incidence rate for females of aboriginal groups =
2.18
Franseschi S,
et al. [14]
2000 United States, Europe,
Asia, Africa, Australia (49
areas worldwide)
Retrospective - - Internationally, OPC highest for men in Bas Rhin, France (49.4/100,000 male
incidence); For men in Americas and Australia, OPC highest for blacks in the
United States (17.8/100,000)
Franseschi S,
et al. [19]
1999 Italy, Switzerland Case-Control 274 oral cancer; 364
pharyngeal cancer
1254 Oral cancer, ≥ 77 drinks/week, ≥ 25 cigarettes/day, OR = 228; Pharyngeal
cancer, > 77 drinks/week, > 25 cigarettes/day, OR = 100
Fioretti F, et
al. [20]
1999 Italy Case-Control 42 (lifelong non-smokers 864 (lifelong
non-smokers
OPC drinkers vs. non drinkers OR = 3.0; OPC drinking 35+ years vs. non
drinking OR = 3.6; High butter intake OR = 2.7
Blot WJ, et
al. [21]
1988 United States Case-Control 1114 1268 Two or more packs cigarettes smoked/day and four or more drinks/day OR =
37.7; Males who smoked filters OR = 0.5
Varela-Lema
L, et al. [22]
2009 Spain Case-Control 92 230 Ever smokers OR = 27.7
Talamini R,
et al. [23]
1990 Italy Case-Control 27 non-smokers; 19 non-
drinkers
572 non-
smokers; 213
non-drinkers
Non-smokers, 14-55 vs. 0-13 alcoholic drinks/week OR = 1.5; Non-smokers, 56+
alcoholic drinks/week, OR = 2.2; Non-drinkers, < 15 cigarettes/day OR = 3.8;
Non-drinkers, > 15 cigarettes/day OR = 12.9
Kabat GC, et
al. [24]
1994 United States Case-Control 1560 2948 Male current smokers, users of filter cigarettes OR = 0.5
Aune D, et
al. [25]
2009 Uruguay Case-Control 3539 2032 High red meat consumption OR = 3.65
Kune GA, et
al. [26]
1993 Australia Case-Control 41 398 Fiber intake OR = 0.29; Vitamin C > 745 mg/week OR = 0.39
Soler M, et
al. [27]
2001 Italy Case-Control 271 oral cancer; 327
pharyngeal cancer; 304
esophageal cancer
1950 Highest fiber intake OR = 0.40
Negri E, et al.
[28]
2000 Italy, Switzerland Case-Control 754 1775 Highest Vitamin C intake OR = 0.63
Lucenteforte
E, et al. [29]
2009 Italy Metanalysis (6
cohort, 40 case-
control studies)
- - High vegetable consumption pooled RR = 0.52; High fruit consumption pooled
RR = 0.55
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7Table 1 OPC literature review: risk and protective factors for OPC (Continued)
Gridley G, et
al. [30]
1992 United States Case-Control 1114 1268 “Ever regularly used” vitamin E, OR = 0.5
Levi F, et al.
[31]
1998 Switzerland Case-Control 156 284 Highest tertile of egg consumption OR = 2.3; Red meat OR = 2.1; Pork and
processed meat OR = 3.2; Highest tertile for milk consumption OR = 0.4; fish
OR = 0.5; raw vegetables OR = 0.3; cooked vegetables OR = 0.1; citrus fruit OR
= 0.4; other fruits OR = 0.2
Franceschi S,
et al. [32]
1999 Italy Case-Control 598 1491 Highest quintile coffee and tea OR = 0.6; Highest quintile white bread OR =
0.4; Highest quintile soups OR = 2.5; Highest quintile poultry OR = 0.6; Highest
quintile fish OR = 0.6; Highest quintile eggs OR = 2.5; Highest quintile raw
vegetables OR = 0.4; Highest quintile cooked vegetables OR = 0.5; Highest
quintile citrus fruit OR = 0.5; Highest quintile cakes and desserts OR = 1.6
Zheng W, et
al. [33]
1992 China Case-Control 204 414 Highest tertile of fruit and vegetable consumption among men OR = 0.6
Lipworth L,
et al. [34]
2009 Italy Case-Control 804 2080 Vitamin D intake OR = 0.76; Heavy smokers and low dietary vitamin D intake
OR = 10.4: Heavy drinkers and low dietary vitamin D intake OR = 8.5
Goldstein
AM, et al.
[35]
1994 United States Case-Control 487 485 Odds for OPC increases for those whose sisters developed other cancers OR =
1.6
Huebner
WW, et al.
[36]
1992 United States Case-Control 1114 1268 Male carpet installers OR = 7.7 (among carpet installers, 23 cases, 4 controls)
Goodwin WJ,
et al. [37]
2008 United States Retrospective - - OPC greater in black than white populations; OPC survival lower in black than
white populations
Morse DE, et
al. [38]
2006 United States Retrospective - - OPC age adjusted incidence rates and mortality rates highest for black males;
Mortality rates 82% higher for black males relative to white males
Tomar SL, et
al. [39]
2004 United States Retrospective 21481 - Blacks had elevated hazard ratios compared to whites HR range: 1.20-1.53
Moore RJ, et
al. [40]
2001 United States Retrospective 909 African-Americans five-year survival rate of 27.6%; white patients five-year
survival rate of 52.0%. African-American and white Americans less than 60 years
of age had a survival rate of 29.2% and 60.9%, respectively.
Chen AY, et
al. [41]
2007 United States Retrospective 40487 - Patients with advanced OPC more likely to be uninsured OR = 1.37
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7control study on meat consumption in Uruguay among
nearly 4,000 cases showed a significant increase in the
odds of having OPC (OR = 3.65, 95% CI 2.21-6.01) with
a high intake of red meat [25]. Several studies have also
found significantly protective effects of fiber intake on
OPC (OR = 0.29, OR = 0.40) [26,27].
Dietary vitamin C consumption of > 745 mg/week was
also shown to protect subjects from developing OPC
(OR = 0.39) [26]. Another study also found that vitamin
C had a similar protective effect (OR = 0.63) [28]. One
study, however, found that vitamin C was protective of
OPC, but noted that vitamin C’se f f e c tw a sd i f f i c u l tt o
separate from the effects of fruit and vegetables intake
[29]. Vitamin E supplements (i.e., “ever regularly used”)
have also been found to be associated with a signifi-
cantly reduced OPC risk with an adjusted OR of 0.5
(95%CI 0.4-0.6) [30]. Other studies have also shown that
consumption of fruits (OR = 0.2), raw (OR = 0.3) and
cooked vegetables (OR = 0.1), and fish (OR = 0.5) had
inverse risks and protective effects on OPC [31,32].
Similar results were found among 414 cases in Shanghai,
China, in that the risks of OPC development decreased
with an increased intake of oranges, tangerines, other
fruits, and some dark yellow vegetables, and white
radishes. The authors found that men in the category
with the highest intake of fruits and vegetables had an
OR of about 0.5-0.7 when compared to men in the low-
est group of fruit and vegetable consumption [33].
Vitamin D intake was also found to have an inverse
risk on OPC (OR = 0.76) [34]. The same study found
that the OR for OPC among heavy smokers with low
dietary vitamin D intake was 10.4 (95%CI 6.9-15.5) and
an OR of 8.5 (95%CI 5.7-12.5) among heavy alcohol
drinkers with low dietary vitamin D intake. When
looked at as a whole, these studies provide substantial
evidence that dietary factors play a very important role
in OPC development.
Other risk factors
Even fewer studies have examined factors besides
tobacco, alcohol, and diet and the relation to OPC
development. A familial-based study found non-signifi-
cant odds ratios associated with any cancer in the
family. However, a slightly elevated OR of 1.6 (95%CI
1.1-2.2) for OPC was found among family members
whose sisters developed cancers [35]. This association,
however, may be due to unaccounted confounders.
Occupational risk factors have also been examined
briefly in the literature. Huebner et al (1992) per-
formed a population-based case-control study in four
United States areas and found elevated OPC risks
among male carpet installers (OR = 7.7, 95%CI 2.4-
24.9) [36]. However, this study only looked at 23 cases
and 4 controls, which presents a clear limitation in the
power of the study.
OPC disparities
Racial disparities
Though much of the literature regarding the risk factors
of OPC is slightly dated, this is not the case for OPC
disparities research. This type of research in the litera-
ture seems relatively new in nature. Much of the litera-
ture shows there to be differences in mortality,
incidence, and survival among black and white males in
the United States. For example, Goodwin et al (2008)
shows there to be an unequal burden or disparity
among black and white Americans with respect to OPC
incidence and survival [37]. They argue that though the
underlying causes of the differences may be unknown,
the differences are likely to arise from several differing
interplays and relationships among various components
such as access to healthcare, quality of care, diet, cul-
tural beliefs, etc. However, the authors argue for further
prospective-cohort studies to more precisely explain the
differences in OPC among black and white Americans
[37]. Furthermore, Morse and Kerr (2006) found that
although age-adjusted incidence rates and mortality
rates declined for black and white males and females
from 1975-2002, disparities still existed between black
and white Americans. The authors found that age-
adjusted mortality rates with black males were 82%
higher than with white males [38].
Within a specific state, a study performed on OPC
survival in Florida found that black Americans had
higher hazard ratios (HR range: 1.20-1.53) than white
Americans across all sites and stages [39]. An interesting
finding of this study was that the differences in survival
were not wholly because of differences in treatment. In
another study, it was found that African-Americans had
a significantly lower five-year survival rate of 27.6%
(95%CI 19.9-38.3) than white patients with a survival
rate of 52.0% (95%CI 48.7-55.6). The greatest racial dis-
parity in survival in this study, interestingly, was found
for patients less than 60 years of age. African-American
and white Americans less than 60 years of age had a
survival rate of 29.2% (95%CI 19.5-43.6) and 60.9% (95%
CI 56.3-66.0), respectively [40]. One of the reasons this
disparity may exist between black and white Americans
is because of a stronger genetic interaction between
smoking and alcohol consumption in black Americans
[40].
Other OPC disparities
In addition, the impact of health insurance status on
stage of diagnosis of OPC has been found to lead to a
late-stage diagnosis. Schrage and Halpern (2007) found
that patients with advanced OPC at diagnosis were
more likely to be uninsured with an OR of 1.37 (95%CI
1.21-1.25) compared with patients who had private
insurance. Similar results were found for patients who
were covered by Medicaid, who presented with the
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node involvement. This study presents a diagnosis dis-
parity based on insurance status. That is, being unin-
sured or on Medicaid increased the odds of presenting
with more advanced and severe OPC, thus increasing
the risk of lower survival [41] (see Table 1).
Interventions
Several other studies have also found racial disparities
for OPC among black and white Americans [42-44].
The recommendations made by these authors for redu-
cing OPC disparities in incidence, mortality, and survival
include early-stage diagnosis and an active role taken by
dentists to reduce smoking and alcohol use among their
patients. Morse and Kerr (2006) argue that dentists
must aid in reducing OPC incidence and mortality by
assisting patients in quitting smoking and eliminating
alcohol abuse [38]. They also argue that relative survival
can be improved through early detection of OPC. Horo-
witz et al (2000) surveyed dentists and found that most
dentists (86%) did not conduct oral cancer examinations
on edentulous patients [45]. This finding spurred the
a u t h o r st oc o n c l u d et h a td e n t i s t sp l a yak e yr o l ei nt h e
determination of early-stage OPC and that dentists must
determine patients’ risks for OPC. This study also
pointed to a need for providing dentists with new edu-
cational updates on OPC prevention and detection [45].
A review paper by Truman et al (2002) on the evi-
dence in the literature on interventions for OPC con-
cluded there was insufficient evidence on the
effectiveness of population-based interventions for early
detection of OPC [46]. This study points to a gap in the
literature regarding interventions on early detection of
pre-cancers and OPC.
Social concerns
One important social issue associated with OPC deals
mainly with the disparity present between black and
white Americans. Though this disparity may potentially
be due to an unaccounted confounder, the burden of
OPC mortality and lower survival is placed heavily on
black Americans. Inability to pay for medical bills,
increased rates of smoking and alcohol use, cultural
beliefs, a late-stage diagnosis of OPC, etc, may be partly
due to the lower survival rates and higher mortality
rates experienced by black Americans with respect to
OPC.
Recommendation and expected outcomes
Improving the incidence, mortality, and survival rates of
OPC requires a multi-tier structural approach that tar-
gets society, dentists, communities, and the individual.
Dentists should encourage their patients to quit smok-
ing and abusing alcohol. In addition, dentists could also
be compensated for reducing smoking rates among their
patient population; this would be a clear incentive for
dentists to engage in their patient population. Silverman
(2001) argues that efforts should be maximized to
increase the early detection of localized lesions and pre-
cancers, coupled with “aggressive” counseling in tobacco
cessation and alcohol use for OPC outcomes to improve
[2].
Reducing smoking rates through the enactment of a
nation-wide smoking ban would also reduce OPC, given
the highly interrelatedness of smoking and OPC. Redu-
cing alcohol consumption should also be targeted. The
number of alcohol outlets can be mitigated by making it
available only in pharmacies. This policy can also be
applied to cigarettes.
Conclusions
This review revealed interesting information about the
literature on OPC. There were several noticeable biases
within the literature, however. Many of the research
articles cited included European study populations.
Populations in non-European countries must be exam-
ined to ensure the relative generalizability of the results.
Also, most of these studies were case-control studies,
and not prospective cohort studies. This presents a lim-
itation in the generalizablitiy and causal inference one
can make from these studies. However, that most of the
studies found similar results highlight the strength of
the association of several of the risk factors (e.g.,
tobacco and alcohol use, and diet) related to OPC.
Future research study designs should be prospective
cohorts with large sample sizes that firmly establish the
risk factors associated with the development of OPC.
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